CD34 and lymphoma: In patients with breast and ovarian cancer, lymphoma and multiple myeloma and in conjunction with G-CSF (Granulocyte Colony Stimulating Factor) SCF is used in clinical practice to mobilise CD34+ cells into peripheral blood [18].